SeQuent Scientific soars on getting EUGMP approval for tablets dosage manufacturing line in Turkey

15 Jul 2021 Evaluate

Sequent Scientific is currently trading at Rs. 285.85, up by 18.05 points or 6.74% from its previous closing of Rs. 267.80 on the BSE.

The scrip opened at Rs. 280.00 and has touched a high and low of Rs. 288.60 and Rs. 275.70 respectively. So far 145323 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 336.40 on 29-Jun-2021 and a 52 week low of Rs. 102.25 on 15-Jul-2020.

Last one week high and low of the scrip stood at Rs. 288.60 and Rs. 266.50 respectively. The current market cap of the company is Rs. 6651.38 crore.

The promoters holding in the company stood at 53.86%, while Institutions and Non-Institutions held 16.36% and 29.77% respectively.

SeQuent Scientific has received EUGMP approval for its tablets dosage manufacturing line in Turkey. The approval was further complimented by the successful renewal of EUGMP license for 8 other manufacturing lines for various dosage forms including beta-lactam, non-beta lactam, terminal sterilization, mastitis, powder beta-lactam, aerosol, pesticide, and solids in Turkey. In addition to the EUGMP, the manufacturing lines in Turkey also hold GMP certificates from Turkish, Saudi, Ethiopian and Sudanese authorities. With these approvals, Alivira now has multiple EUGMP approved facilities globally, allowing it to better serve the needs of its customers in the regulated markets of Europe, and access to alternative manufacturing sites to ensure supply of high quality products.

With over 120 product registrations, SeQuent is the third-largest player in the Turkish ruminant market with a consolidated market share of 10%, operating through its 100% subsidiaries of Provet and Topkim. The company has already embarked upon significant expansion in Turkey to meet the growing requirements of the local market along with leveraging the sites for European and other strategic markets.

Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. Sequent is the world's largest producer of Anthelmintics and by far the strongest player in the Veterinary API business.

Sequent Scientific Share Price

201.70 9.60 (5.00%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.